冠動脈疾患(CAD) (虚血性心疾患)：治療薬のグローバル治験動向（2014年下半期）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 7
Coronary Artery Disease (CAD) (Ischemic Heart Disease) 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Five Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Coronary Artery Disease (CAD) (Ischemic Heart Disease) to Cardiovascular Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Coronary Artery Disease (CAD) (Ischemic Heart Disease) 26
Subjects Recruited Over a Period of Time 35
Clinical Trials by Sponsor Type 36
Prominent Sponsors 37
Top Companies Participating in Coronary Artery Disease (CAD) (Ischemic Heart Disease) Therapeutics Clinical Trials 38
Prominent Drugs 40
Clinical Trial Profiles 41
Clinical Trial Overview of Top Companies 41
AstraZeneca PLC 41
Clinical Trial Overview of AstraZeneca PLC 41
Pfizer Inc. 44
Clinical Trial Overview of Pfizer Inc. 44
Daiichi Sankyo Company, Limited 46
Clinical Trial Overview of Daiichi Sankyo Company, Limited 46
Abbott Laboratories 48
Clinical Trial Overview of Abbott Laboratories 48
Bristol-Myers Squibb Company 50
Clinical Trial Overview of Bristol-Myers Squibb Company 50
Astellas Pharma Inc. 52
Clinical Trial Overview of Astellas Pharma Inc. 52
Medtronic, Inc. 54
Clinical Trial Overview of Medtronic, Inc. 54
Boston Scientific Corporation 56
Clinical Trial Overview of Boston Scientific Corporation 56
Merck & Co., Inc. 58
Clinical Trial Overview of Merck & Co., Inc. 58
Eli Lilly and Company 60
Clinical Trial Overview of Eli Lilly and Company 60
Clinical Trial Overview of Top Institutes / Government 62
National Heart, Lung, and Blood Institute 62
Clinical Trial Overview of National Heart, Lung, and Blood Institute 62
Seoul National University Hospital 65
Clinical Trial Overview of Seoul National University Hospital 65
Yonsei University 67
Clinical Trial Overview of Yonsei University 67
Cardiovascular Research Foundation 69
Clinical Trial Overview of Cardiovascular Research Foundation 69
Kumamoto University 71
Clinical Trial Overview of Kumamoto University 71
University of Florida 73
Clinical Trial Overview of University of Florida 73
Tehran University of Medical Sciences 74
Clinical Trial Overview of Tehran University of Medical Sciences 74
Emory University 75
Clinical Trial Overview of Emory University 75
Medical University of Vienna 76
Clinical Trial Overview of Medical University of Vienna 76
Kyoto University 77
Clinical Trial Overview of Kyoto University 77
Five Key Clinical Profiles 78
Appendix 98
Abbreviations 98
Definitions 98
Research Methodology 99
Secondary Research 99
About GlobalData 100
Contact Us 100
Disclaimer 100
Source 100